Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) Enterprise Value: 2020-2024

Historic Enterprise Value for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to -$400.0 million.

  • Agilon Health's Enterprise Value rose 2088.76% to -$310.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$310.9 million, marking a year-over-year increase of 2088.76%. This contributed to the annual value of -$400.0 million for FY2024, which is 1823.39% up from last year.
  • As of FY2024, Agilon Health's Enterprise Value stood at -$400.0 million, which was up 1823.39% from -$489.2 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Enterprise Value registered a high of -$106.8 million during FY2020, and its lowest value of -$1.0 billion during FY2021.
  • Moreover, its 5-year median value for Enterprise Value was -$489.2 million (2023), whereas its average is -$582.8 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 87414.58% in 2021, then skyrocketed by 4427.51% in 2023.
  • Annual analysis of 5 years shows Agilon Health's Enterprise Value stood at -$106.8 million in 2020, then tumbled by 874.15% to -$1.0 billion in 2021, then rose by 15.62% to -$877.8 million in 2022, then skyrocketed by 44.28% to -$489.2 million in 2023, then rose by 18.23% to -$400.0 million in 2024.
  • Its last three reported values are -$400.0 million in FY2024, -$489.2 million for FY2023, and -$877.8 million during FY2022.